Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture.
about
Targeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issueLysophospholipids and their receptors in the central nervous systemBrain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration.Lysophosphatidic Acid signaling in the nervous system.Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer CellsMicroglial M1/M2 polarization and metabolic states.Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's diseaseSDF-1α and LPA modulate microglia potassium channels through rho gtpases to regulate cell morphology.Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers.Proteome of brain glia: the molecular basis of diverse glial phenotypes.Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease.Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders.Microglial brain region-dependent diversity and selective regional sensitivities to aging.Stress, depression, resilience and ageing: A role for the LPA-LPA1 pathway.Rho-Associated Kinase Inhibitors Promote Microglial Uptake Via the ERK Signaling Pathway.Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation.Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin.LPA-induced suppression of periostin in human osteosarcoma cells is mediated by the LPA(1)/Egr-1 axis.14-3-3ε marks the amyloid-stimulated microglia long-term activation.1-Oleyl-lysophosphatidic acid (LPA) promotes polarization of BV-2 and primary murine microglia towards an M1-like phenotype.Bioenergetic regulation of microglia.Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype.Developmental changes in lysophospholipid receptor expression in rodent heart from near-term fetus to adult.The Rho-associated kinase inhibitors Y27632 and fasudil promote microglial migration in the spinal cord via the ERK signaling pathway.
P2860
Q26852041-F7BC4DC2-21B1-471E-A8D1-375F0310F2A4Q26859168-4015388D-567D-4D4C-8078-F50D22EAEA5DQ33627982-56E343B1-AA77-44DA-9E43-CA691AF8EE3DQ35456340-7B8A7049-DCD8-4100-8EB2-C644D56409A5Q35551835-F3A9645B-B143-4AEA-BAE7-9CA77AAF4F9DQ36177654-FD8354F1-1C9D-48FC-8B70-6CB93F7EB4C5Q36547001-24870E7E-E892-4AB3-823E-795CBE58FC98Q36576487-3DF52BCF-3E41-4423-BF27-76B053DE8029Q36666708-2ECF3998-C08A-413A-ABB6-90B83F0CC85CQ37727199-38BEEBA1-4066-4645-B25A-B6EA2A69B8D1Q38152439-54A21275-DB1A-4EE0-8E59-9278AE5595E6Q38260925-8E6BEDB1-7C2C-4DB5-8783-46047477A8F7Q38530085-CE27CB11-5DBF-4661-ADE0-9D2434B08D58Q38642851-3BA24A20-8621-4678-9699-1416F1AEACE8Q38658765-0668C49F-59B4-43B8-B137-D2759996C18CQ38802430-E272C7B8-B625-4FD9-AB94-8BE774B8861BQ38942116-6A9DE735-5316-481F-BB09-AC24063FDD91Q39055955-2BE40A07-7F00-4671-BE82-888602B15243Q39338040-5D9A3CA8-3784-4A6C-BF10-C470367029C4Q39446552-9798312D-20B0-43D7-B0B4-E344458CF48FQ40960816-28FA58F2-7543-4743-B8C9-DC2FFC0D87C1Q46004195-3D5E8B1B-FFAA-46F0-ACD4-0BBF08CBCE25Q47118425-ABA35F84-D0D6-4B23-96A8-7C41FD48C4ECQ50799052-3247CB9B-ABBB-40C0-8713-9B0EB3A976FFQ54112689-AEBBB76C-DCEA-4712-9F18-1CDF3DC06BE6
P2860
Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Lysophosphatidic acid receptor ...... and cytoskeletal architecture.
@en
Lysophosphatidic acid receptor ...... and cytoskeletal architecture.
@nl
type
label
Lysophosphatidic acid receptor ...... and cytoskeletal architecture.
@en
Lysophosphatidic acid receptor ...... and cytoskeletal architecture.
@nl
prefLabel
Lysophosphatidic acid receptor ...... and cytoskeletal architecture.
@en
Lysophosphatidic acid receptor ...... and cytoskeletal architecture.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Lysophosphatidic acid receptor ...... and cytoskeletal architecture.
@en
P2093
Andrea Wintersperger
Christoph Nusshold
Ernst Malle
Eva Bernhart
Gerald Rechberger
Helga Reicher
Klaus Zorn-Pauly
Manfred Kollroser
Petra Schratl
Seth Hallström
P2860
P304
P356
10.1002/PMIC.200900195
P577
2010-01-01T00:00:00Z